Serratus Posterior Superior vs Erector Spinae Plane Block for Breast Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
Serratus posterior superior intercostal plane block: Participants in this group will receive an ultrasound-guided serratus posterior superior intercostal plane (SPSIP) block for postoperative analgesia following mastectomy. The block will be performed under standardized conditions prior to surgery according to the study protocol.
Erector Spinae Plane Block: Participants in this group will receive an ultrasound-guided erector spinae plane (ESP) block for postoperative analgesia following mastectomy. The block will be performed under standardized conditions prior to surgery according to the study protocol.
Study summary
Postoperative pain after mastectomy remains a significant clinical problem that may impair patient comfort and delay early rehabilitation, potentially affecting functional recovery. Various analgesic techniques are used to manage postoperative pain. This study aims to compare serratus posterior superior intercostal plane block and erector spinae plane block, which are routinely used in our clinic for postoperative analgesia in patients undergoing mastectomy, in terms of ease of application and patient comfort.
Eligibility
Primary outcome measure(s)
- Ease of block application (procedure difficulty score) — Immediately after block performance
The ease of application of the block will be evaluated using a 10-point numerical rating scale (0-10), where lower scores indicate easier application and higher scores indicate greater procedural difficulty. The score will be assigned by the anesthesiologist performing the block immediately after completion of the procedure.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Sakarya University-Anesthesiology and Reanimation Department | Sakarya | Turkey (Türkiye) | Recruiting |
More Sakarya University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07561853 on ClinicalTrials.gov ↗ ← All trials in Turkey